These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 75119)

  • 21. Neuraminidase antibodies in serum and nasal washings after immunization by means of live and killed whole virion, split virion and subunit (HA and N) influenza vaccines.
    Kuwert EK; Höher PG; Werner J; Scheiermann N; Thraenhart O; Müller B; Kleber G
    Dev Biol Stand; 1977 Jun 1-3; 39():77-83. PubMed ID: 604137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Formation and persistence of antibodies against envelope antigens of influenza virus after vaccination by formolized monovaccine (author's transl)].
    Stumpa A; Bruj J; Tůmová B; Skocil V
    Cesk Epidemiol Mikrobiol Imunol; 1978 Feb; 27(1):29-37. PubMed ID: 149598
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of neuraminidase on potency of inactivated influenza virus vaccines in mice.
    Reichert E; Mauler R
    Dev Biol Stand; 1975; 28():319-23. PubMed ID: 1126575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuraminidase assay of influenza vaccines.
    Bevan AM; Furminger IG; Smith CH
    Dev Biol Stand; 1975; 28():173-80. PubMed ID: 1126567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.
    Muhamed G; Greenbaum E; Zakay-Rones Z
    Isr Med Assoc J; 2006 Mar; 8(3):155-8. PubMed ID: 16599048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
    Beutner KR; Rizzone C; DeMello S; Ogra PL
    Dev Biol Stand; 1976; 33():162-70. PubMed ID: 782964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evaluation of influenza A/Victoria/3/75-ts-1 [E] recombinant viruses for attenuation and immunogenicity in adult seronegative volunteers.
    Murphy BR; Markoff LJ; Chanock RM; Douglas RG; Betts RF; Cate TR; Couch RB
    Dev Biol Stand; 1977 Jun 1-3; 39():47-52. PubMed ID: 604132
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antibody response to hemagglutinin and neuraminidase induced by an influenza subunit vaccine (author's transl)].
    Kuwert E; Werner J; Franke G; Paulus W
    Zentralbl Bakteriol Orig A; 1979 Jun; 244(1):1-16. PubMed ID: 92113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
    Li S; Liu C; Klimov A; Subbarao K; Perdue ML; Mo D; Ji Y; Woods L; Hietala S; Bryant M
    J Infect Dis; 1999 May; 179(5):1132-8. PubMed ID: 10191214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of immunoenzyme analysis for detecting secretory and serum antibodies in those vaccinated with live influenza vaccine].
    Kozhukhov VM; Orlov VA; Zhilova GP; Malikova EV
    Tr Inst Im Pastera; 1988; 64():120-6. PubMed ID: 3077710
    [No Abstract]   [Full Text] [Related]  

  • 32. Attenuated ts-recombinants of influenza A/USSR/77 (H1N1) virus obtained by crossing with the cold-adapted donor A/Leningrad/134/57 (H2N2) virus.
    Polezhaev FI; Garmashova LM; Koval TA; Taranova GP; Topuriya NV; Aleksandrova GI
    Acta Virol; 1982 Jul; 26(4):221-6. PubMed ID: 6127928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistence of influenza A/New Jersey/76 (Hsw1N1) antibody one year after vaccination.
    Noble GR; Kaye HS; O'Brien RJ; Kendal AP; Bregman DJ; Wright PF; Amler RW; Dowdle WR
    Dev Biol Stand; 1977 Jun 1-3; 39():253-60. PubMed ID: 604107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates.
    Lambré CR; Terzidis H; Greffard A; Webster RG
    J Immunol Methods; 1990 Dec; 135(1-2):49-57. PubMed ID: 1703190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Determination of the neuraminidase specificity of influenza A and B viruses using a modified lectin test].
    Liubovtseva OV; Zakstel'skaia LIa; Ivanova VT; Oskerko TA
    Vopr Virusol; 1983; 28(6):663-8. PubMed ID: 6199899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influenza antineuraminidase antibodies studied by a modified method].
    Paramonova MS
    Vopr Virusol; 1986; 31(3):361-4. PubMed ID: 3532547
    [No Abstract]   [Full Text] [Related]  

  • 37. The assay of influenza antineuraminidase activity by an elution inhibition technique.
    Appleyard G; Oram JD
    J Gen Virol; 1977 Jan; 34(1):137-44. PubMed ID: 319203
    [No Abstract]   [Full Text] [Related]  

  • 38. [Determination of standard conditions for the influenza virus neuraminidase inhibition test].
    Mel'nikova SK; Gracheva EN; Alekseeva AK
    Vopr Virusol; 1976; (3):283-7. PubMed ID: 988673
    [No Abstract]   [Full Text] [Related]  

  • 39. [Optimization of a method for setting up the neuraminidase activity inhibition reaction (author's transl)].
    Paramonova MS; Golubev DB
    Vopr Virusol; 1975; (5):628-31. PubMed ID: 1108453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents.
    Phelan MA; Mayner RE; Bucher DJ; Ennis FA
    J Biol Stand; 1980; 8(3):233-42. PubMed ID: 7410447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.